I know you didn't ask me, but I say 'yes'. The $0.92 we saw earlier this week was close the 52 week floor. The stock has been range-bound over that time with a peak north of $1.50.
Even if that pattern continues, that's a 50% upside from today that over the same time period has taken about 2 months to achieve. Add in an announcement on the clinical trial site for the COVID therapy and we can get up there faster and higher if we're lucky. Don't know if this is a buy-and hold stock though.
Yeah Mick, I do, but I've been BLINDED BY THE LIGHT before, as you know:). As Foose notes with last week's COVID announcement, we should be getting a bit of a ride UP for a decent take for you at this level. Here's a link to pretty encouraging article in English to an Arabic sites article on TYME-19 for COVID 19.
It's not a vaccine that would prevent COVID, it's a remedy for active COVID (asymptomatic carriers and those active patients in trouble[/tag]
Shot my powder here a couple of days ago. You can still catch FOOSE!:)
Yeah Mick, all this action is new for us:) Let me post this link up to EDGAR site listing two insider buying forms loaded up after-market yesterday where 60K insider options were exercised at 95/96 cents. I now say probably the trigger(s) for pre-market drop today vs. the end of Days to Cover factor hanging live till 1 PM US Eastern Standard Time today.
James Beih and Michael Douglas both buying in. Insiders, not primary insiders, but insiders, hence the Form 4's. Actually, shorts have added a lot of volume along with volatility to our little pile of gold, there is a benefit, and we have a huge number our Outstanding Shares and what has been exceedingly low volume.
Day traders did bring us ACTION Shorting and other trading action over on Depository Trust and Clearing Corporation's HIGH ROLLER exchange is something we should be aware of and looking at.
On that, a repetitive criticism of TYME from analysts is our HEAVY INSIDER HOLDINGs and low INSTITUTIONAL holdings (too risky/no income YET?). Gotta get my assets off to work. Get back here a bit later.
News 
Market Data 
Discover 
AI
